white matter lesions

55
hite Matter Lesion Marie Beckner, MD Idiopathic demyelinating disease (MS) described in this module: yelinating diseases, “leukodystrophies ctious demyelination (PML) -infectious demyelination (cross rx to Acquired metabolic demyelination . Toxic leukoencephalopathies

Upload: ursula

Post on 11-Jan-2016

62 views

Category:

Documents


4 download

DESCRIPTION

White Matter Lesions. Marie Beckner, MD. 1. Idiopathic demyelinating disease (MS). 2. Acquired metabolic demyelination. 3. Toxic leukoencephalopathies. Not described in this module: Dysmyelinating diseases, “leukodystrophies” Infectious demyelination (PML) - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: White Matter Lesions

White Matter LesionsMarie Beckner, MD

1. Idiopathic demyelinating disease (MS)

Not described in this module:Dysmyelinating diseases, “leukodystrophies”Infectious demyelination (PML)Post-infectious demyelination (cross rx to Ag)

2. Acquired metabolic demyelination

3. Toxic leukoencephalopathies

Page 2: White Matter Lesions

Primary Demyelination

Damage to oligodendroglia & their myelin sheaths Axons are relatively preserved

Secondary Demyelination

Damaged axon loss of myelin Axonal transectionWallerian degeneration in distal portion

Page 3: White Matter Lesions

1. MULTIPLE SCLEROSIS

First described in 1870’s

Chronic, idiopathic, inflammatorydemyelinating disease of CNS

Selective destrx of oligodendrocytes & myelin with preserved axons

Foci (plaques) widely dispersed in CNS

?Environmental influence acting upon genetically susceptible individuals

Page 4: White Matter Lesions

Multiple Sclerosis

Higher prevalence in colder climates

1 million worldwide, increasing rate

CNS lesions disseminated in space & time

Symptoms: Paresthesias, gait difficulty, weakness/incoordination of 1 or both lower extremities, visual changes

Page 5: White Matter Lesions

MS - Magnetic Resonance Imaging

MRI: T1, T2, FLAIR (fluid-attenuated inversion recovery) New lesions Gadolinium enhancement (recent disruption of blood brain barrier)

Monitoring may help to identify agents that may be active against early inflammatory stage of MS

Page 6: White Matter Lesions

Axial FLAIR

Periventricular hyperintense WM lesions

Hx: 25 yr woman with relapsing- remitting MS

NEJM 343:938-52, 2000

Page 7: White Matter Lesions

9 months later

Axial FLAIR

number & size ofWM lesions

NEJM 343:938-52, 2000

Page 8: White Matter Lesions

With gadolinium

Many lesions demonstrate ring or peripheral enhancement

NEJM 343:938-52, 2000

Page 9: White Matter Lesions

T1-weighted MRIMultiple regionsof diminishedsignal, “blackholes”, in peri-ventricularWM and corpuscallosum. Chronic lesionsof MS.

NEJM 343:938-52, 2000

Page 10: White Matter Lesions

MS - Demyelinated PlaquesWell-demarcated, gray, gelatinous

S. Schochet

Page 11: White Matter Lesions

MS Plaque, often periventricular

Lateral Ventricle

Ellison & Love

Page 12: White Matter Lesions

MS Plaque

Dawson’s fingers?

Extensions alongblood vessels

Rarely see layers ofdemyelinated & morenormally myelinatedwhite matter (not here)

Robbins, 6th ed.

Page 13: White Matter Lesions

Shadow Plaques - partial myelination adjacent to complete demyelination

GRIPE

Page 14: White Matter Lesions

MS Plaque with H&E Stain

Univ. Utah

Page 15: White Matter Lesions

MS Plaque

Luxol FastBlue Stain

Univ. Utah

Page 16: White Matter Lesions

MS Plaque - Luxol Fast Blue Stain

Univ. Utah

Page 17: White Matter Lesions

MS Plaque with Bodian Stain - Axons

Univ. Utah

Page 18: White Matter Lesions

MS Demyelinated PlaquesLoss of myelin (Luxol Fast Blue Stain)

Perivascularlymphocytes

Robbins, 6th ed., 2000

Page 19: White Matter Lesions

MS Demyelinated Plaques

Preservation of axons

Robbins, 6th ed., 2000

Page 20: White Matter Lesions

MS - Perivascular Lymphocytes

Univ. Utah

Page 21: White Matter Lesions

MS-lymphocytes & reactive astrocytes

Univ. Utah

Page 22: White Matter Lesions

MS-lymphocytes & reactive astrocytes

Enlarged, atypical nuclei, not hyperchromatic

Univ. Utah

Page 23: White Matter Lesions

MS Plaque - Subacute - Macrophages

Univ. Utah

Page 24: White Matter Lesions

MS Plaque - Subacute - Macrophages

Gitter cells - myelin breakdown products

Univ. Utah

Page 25: White Matter Lesions

Creutzfeldt cell with minute chromatinfragments

Often found inacute plaques of MS or inastrocytomas.Short-lived dueto cell degen-eration.

NEJM 339:542-9,1998

Page 26: White Matter Lesions

Multiple SclerosisOther locations for plaques?

Optic nerves, brain stem, cerebellum,spinal cord white matter, etc.

What is Devic’s Disease?

Demyelinating lesions of optic nerve(s) & spinal cord (neuromyelitis optica)Clinically, 30-40 yr, acute onset and often rapidly progressive

Page 27: White Matter Lesions

Ellison & Love

Devic’sDisease

Optic Nerve

Page 28: White Matter Lesions

Multiple Sclerosis - TestsCSF: IgG oligoclonal bands or IgG

and lymphocytes (<50 cells)

Abnormal evoked potential studies: central conduction velocities

MRI: Abnormal in 95% patientsGadolinium enhanced lesions 5-10X > than clinical relapses Basis for future clinical trials as an outcome measure

Page 29: White Matter Lesions

MS Clinical CategoriesRelapsing-remitting - episodes of acute worsening w/ recovery & a stable course between relapses

Secondary progressive - gradual neurologic deterioration w/ or w/o superimposed acute relapses in a patient who previously had relapsing-remitting MS

Primary progressive - gradual, nearly continuous neurologic deterioration from the onset of sympt.

Progressive relapsing - gradual neurologic deterioration from the onset of symptoms but with subsequent superimposed relapse

Page 30: White Matter Lesions

MS Variants - Clinical Progression

Charcot type - most common (variable) relapsing-remitting - signs & symptoms w/n days recovery(wks) many develop secondary progression with persistent - signs of CNS dysfunction after relapse - disease may progress between relapses

10% benign MS - do well > 20 years10% primary progressive MS - older patients, chronic progressive myelopathyRare -Progressive relapsing MS

Page 31: White Matter Lesions

Rare MS Variants

Acute MS (Marburg variant) Fulminant, rapid downhill course (fatal w/n months or 1 year) Younger patients Prominent tissue destruction in addition to demyelination CT & MRI lesions may be suspicious due to mass effect & edema and are then biopsied

Page 32: White Matter Lesions

Acute (Marburg-type) MS

Page 33: White Matter Lesions

Rare MS Variants cont...

Bihemispheric widespread demyelinationScattered typical MS plaquesAxonal injury, cavitation, & Wallerian degeneration with sparing of U fibersLeukodystrophy must be excludedDiff. Dx. Of “mental deterioration” in adolescents

Schilder’s Disease (diffuse sclerosis)

Page 34: White Matter Lesions

Rare MS Variants cont...

Balo’s Concentric Sclerosis

Young patientsAcute onset with strokelike symptomsAbsence of remissions & exacerbationsAffected tissue looks layered (onionskin) demyelinated white matter and more myelinated white matter (maybe due to remyelination)

Page 35: White Matter Lesions

Concentric Sclerosis (Balo’s Disease)

Page 36: White Matter Lesions

2. Acquired Metabolic Demyelination

Central pontine myelinolysis (CPM)

Multifocal necrotizing leukoencephalopathy (MNL)

Marchiafava-Bignami disease

Osmotic demyelination syndromes ?

Page 37: White Matter Lesions

Central Pontine Myelinolysis

Rapid serum Na+in hyponatremic patient,(chronic liver dz, alcoholics)Very similar to MS plaque

What is the typical clinical scenario?

Page 38: White Matter Lesions

Central Pontine Myelinolysis

S. Schochet

Page 39: White Matter Lesions

Multifocal Necrotizing Leukoencephalopathy (MNL)

Foci of necrosis with Ca++, WM > GM

Formerly “focal pontine leukoencephalopathy”

Predominantly immunosuppressed patients (AIDS, leukemia, irradiation, amphotericin B, methotrexate, other cytotoxic drugs)

Clinically - complex neurologic abnormalities in patients with long critical illnesses

Page 40: White Matter Lesions

Multifocal Necrotizing Leukoencephalopathy

- ill-defined chalky white foci- distributed in pons and white matter

Ellison and Love, Fig. 22.33, 1998

Page 41: White Matter Lesions

MNL

- spongy vacuolation - swollen axons (may Ca++)- macrophages - foci often microscopic

Page 42: White Matter Lesions

Marchiafava - Bignami Disease

Rare complication of alcoholism

Destruction of myelinated fibersDegeneration of corpus callosum & anterior commissure

Loss of callosal fiberscortical laminar sclerosisMorel’s laminar sclerosis (frontal & temporal cortex, usually layer III)

Page 43: White Matter Lesions

Marchiafava - Bignami Disease

Ellison & Love

Page 44: White Matter Lesions

3. Toxic Leukoencephalopathy

Variability: Diverse mechanisms Target of injury (myelin, astrocytes, blood vessels, etc.)

Etiologies: Cranial irradiation Therapeutic drugs (antineoplastics) Drugs of abuse (cocaine, heroin, ecstasy or MDMA, toluene, etc.) Environmental solvents (organic solvents)

Page 45: White Matter Lesions

Targets of Toxins in Cerebral WM

Filley & Kleinschmidt-DeMasters, NEJM, 2001

Page 46: White Matter Lesions

Toxic Leukoencephalopathies

Clinical: WM tracts for higher cerebral function affected Inattention

Forgetfulness Changes in personality

Dementia Coma Death Absence of aphasia, language preserved

Page 47: White Matter Lesions

Cranial Irradiation

More common for whole brain > local field

Neurobehavioral dysfunction in 28%

3 stages: acute reaction - patchy, reversible WM edema delayed reaction - widespread edema & demyelination severe delayed reaction - loss of myelin and axons due to vascular necrosis and thrombosis

Page 48: White Matter Lesions

Chemotherapy Drugs

Especially those given intrathecallyEspecially when given with irradiationMethotrexate - discrete or confluent necrosis - can cause MNL - vascular lesions in someCarmustineOthers (cisplatin, cytarabrine, fluorouracil, levamisole, fludarabine, thiopeta)Sometimes IL-2, interferon-alpha

Page 49: White Matter Lesions

T2-MRI in man withright frontal GBMafter radiation &chemotherapywith carmustineshowssymmetrichyperintensityof the cerebralwhite matter (2 arrows)

Filley & Kleinschmidt-DeMastsers, NEJM, p.428, 2001

Page 50: White Matter Lesions

Methotrexate Toxicity

6 yrold girl treatedintrathecallyfor leukemia withCNS relapses

Page 51: White Matter Lesions

Methotrexate Toxicity

Swollen axons, many are mineralized

Page 52: White Matter Lesions

TolueneSpray paints, varnishes,thinners, dyes, glues, histology reagents, &aviation fuels

Abused as an inhalant(glue-sniffing)

Myelin degradationT2 MRI in man with dementiaand long-term toluene abuseSymmetric hyperintensity ofWM & ventricular enlargement

Page 53: White Matter Lesions

Ethanol Leukotoxicity

Alcoholics have hyperintense WM foci - MRI

Frontal WM preferentially affected

Fetal alcohol syndrome - delayed myelination & agenesis of the corpus callosum

Marchiafava - Bignami

Atrophy of corpus callosum with necrosis

Dz already discussed?

Page 54: White Matter Lesions

MDMA (“Ecstasy”)

3,4 - methylenedioxymethamphetamine

1999 - 8% U.S. high school seniors

Serotoninergic axonal injury

Oxidative stress damages myelin

Page 55: White Matter Lesions

End of this module

Please send suggestions [email protected]